By pinki@katapult.biz / February 13, 2025 ← Go back Approach to NSCLC With Targetable Mutations (EGFR, ALK and ROS-1)Jorge J Nieva, M.D.← Go back Approach to NSCLC With Targetable Mutations (EGFR, ALK and ROS-1)Jorge J Nieva, M.D.
